Bordetella pertussis serology in pregnancy.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON26049

Enrollment

500

Registered

2005-10-02

Start date

2002-08-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

This study is to study prospectively the incidence of B.pertussis infection in pregnant women in the Groene Hart Hospital in Gouda, the Netherlands. Therefore bloodsamples will be taken from the mother at 12 weeks gestation, at delivery and 2 months after delivery. Also cord blood will be collected at delivery. In these blood samples IgG against pertussis toxin and IgA against whole cell B.pertussis will be measured (RIVM). Also the mothers will be asked to fill in questionaires.

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: All pregnant women delivering at the department of gynecology and obstetrics of the Groene Hart Hospital.

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

Measure	Time frame
1. Positive B.pertussis serology; 2. Cata questionnaires.	—

Contacts

Public ContactJ.C.M. Huisseling, van

Groene Hart Hospital, P.O. Box 1098

hans.vanhuisseling@ghz.nl(0)31 (0)182 505050

Outcome results